Brief: Aap Implantate post Q2 EBITDA loss from continued oprations of 1.4 mln euros

aap Implantate AG

12/08/2016 16:28

Aug 12 (Reuters) - Aap Implantate AG  AAQG.DE : 
    * In the continued operation sales and EBITDA in Q2/2016 at 
3.4 million euros ($3.80 million) (guidance: 2.5 million euros 
to 3.5 million euros) and -1.4 million euros (guidance: -2.5 
million euros to -1.5 million euros) respectively 
    * In Q3 of 2016, aap aims to achieve further progress in its 
strategy implementation 
    * For Q3 of 2016, aap is expecting for continued operation 
sales to range between 2.5 million euros and 4.0 million euros 
and an EBITDA of -2.0 million euros to -1.2 million euros 
 
Source text for Eikon:  ID:nHUG43vF4D  
Further company coverage:  AAQG.DE  
 
($1 = 0.8949 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))